Description
GLOW is a three-peptide research blend combining GHK-Cu, BPC-157 and TB-500. It is primarily associated with skin remodelling, connective-tissue research, wound healing, and regenerative pathways.
The combination is a community-created formulation rather than a single molecule.
Product Information
GHK-Cu is a copper-binding tripeptide associated with extracellular matrix remodelling. BPC-157 is investigated mainly in tissue-repair models, while TB-500 is related to thymosin-beta-4 signalling.
Current research supports the individual peptides much more strongly than the blend itself.
How Does It Work?
The blend combines GHK-Cu’s matrix-remodeling pathways with BPC-157 and TB-500 tissue-repair signalling.
Benefits
Skin and Collagen Research
GHK-Cu is extensively studied in relation to collagen production, extracellular matrix remodelling, and skin repair, making it the primary cosmetic-research component.
Tissue-Repair Research
BPC-157 research has focused on tendon, ligament, muscle and gastrointestinal tissue models, while TB-500-related research focuses on cell migration and wound closure.
Wound-Healing Research
The three peptides converge on several repair-related pathways, including cell migration, angiogenesis, and extracellular matrix remodelling.
Regenerative Research
The blend’s popularity comes from combining three different research pathways rather than relying on one peptide. However, no controlled clinical trial has established that GLOW itself produces synergistic effects.



